Related Experiment Video
Updated: Jun 23, 2026

Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
Published on: August 15, 2014
Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal fluid
Alfonso Salvatore1, Luisa Cigliano, Alessandro Carlucci
1Dipartimento delle Scienze Biologiche Università di Napoli Federico II, Mezzocannone, Napoli, Italia.
Haptoglobin binds and protects apolipoprotein E (ApoE) and apolipoprotein A-I (ApoA-I) from oxidative damage. This binding preserves their function in cholesterol esterification, aiding brain cholesterol elimination.
Area of Science:
- Biochemistry
- Neuroscience
- Lipid Metabolism
Background:
- Haptoglobin (Hpt) binds apolipoprotein A-I (ApoA-I), protecting it from oxidative damage and preserving lecithin-cholesterol acyltransferase (LCAT) stimulation.
- Oxidative stress impacts lipid metabolism and protein function in neurological conditions.
Purpose of the Study:
- To investigate Haptoglobin's interaction with apolipoprotein E (ApoE).
- To determine if Haptoglobin protects ApoE from oxidative modification.
- To explore the role of Haptoglobin, ApoA-I, and ApoE in cholesterol metabolism in cerebrospinal fluid (CSF).
Main Methods:
- Mapping Haptoglobin binding sites on ApoE using synthetic peptides.
- In vitro oxidative modification assays using hydroxyl radicals.
- Immunoblotting to detect ApoE-containing adducts.
- Analysis of CSF from multiple sclerosis patients and controls for lipid and protein levels.
Main Results:
- Haptoglobin binds to ApoE at a site homologous to its binding site on ApoA-I.
- Haptoglobin inhibited hydroxyl radical-induced oxidative modification of ApoE in vitro.
- Oxidized ApoE and ApoA-I were detected in CSF of patients and controls.
- The ratio of cholesteryl esters to unesterified cholesterol correlated inversely with the [Hpt]/([ApoE]+[ApoA-I]) ratio in CSF.
Conclusions:
- Haptoglobin protects both ApoA-I and ApoE from oxidative damage.
- Haptoglobin may preserve the function of ApoA-I and ApoE in cholesterol esterification.
- This protective mechanism may contribute to cholesterol elimination from the brain.
Related Concept Videos
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Cholesterol: Significance and Regulation
Considering cholesterol and...

